37 related articles for article (PubMed ID: 9499439)
21. Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.
Zhang C; Cortez NG; Berns KI
Hum Gene Ther; 2007 Sep; 18(9):787-97. PubMed ID: 17760515
[TBL] [Abstract][Full Text] [Related]
22. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells.
Ponnazhagan S; Erikson D; Kearns WG; Zhou SZ; Nahreini P; Wang XS; Srivastava A
Hum Gene Ther; 1997 Feb; 8(3):275-84. PubMed ID: 9048194
[TBL] [Abstract][Full Text] [Related]
23. Site-specific integration by the adeno-associated virus rep protein.
Recchia A; Mavilio F
Curr Gene Ther; 2011 Oct; 11(5):399-405. PubMed ID: 21827397
[TBL] [Abstract][Full Text] [Related]
24. Adeno-associated virus gene transfer into renal cells: potential for in vivo gene delivery.
Langer JC; Klotman ME; Hanss B; Tulchin N; Bruggeman LA; Klotman PE; Lipkowitz MS
Exp Nephrol; 1998; 6(3):189-94. PubMed ID: 9639033
[TBL] [Abstract][Full Text] [Related]
25. Adeno-associated virus vectors.
Carter BJ
Curr Opin Biotechnol; 1992 Oct; 3(5):533-9. PubMed ID: 1369403
[TBL] [Abstract][Full Text] [Related]
26. The Role of Recombinant AAV in Precise Genome Editing.
Bijlani S; Pang KM; Sivanandam V; Singh A; Chatterjee S
Front Genome Ed; 2021; 3():799722. PubMed ID: 35098210
[TBL] [Abstract][Full Text] [Related]
27. Sites of recombinant adeno-associated virus integration.
Rivadeneira ED; Popescu NC; Zimonjic DB; Cheng GS; Nelson PJ; Ross MD; DiPaolo JA; Klotman ME
Int J Oncol; 1998 Apr; 12(4):805-10. PubMed ID: 9499439
[TBL] [Abstract][Full Text] [Related]
28. Site-specific integration by adeno-associated virus.
Linden RM; Ward P; Giraud C; Winocour E; Berns KI
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11288-94. PubMed ID: 8876128
[TBL] [Abstract][Full Text] [Related]
29. Adeno-associated virus integration: virus versus vector.
Smith RH
Gene Ther; 2008 Jun; 15(11):817-22. PubMed ID: 18401436
[TBL] [Abstract][Full Text] [Related]
30. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
McCarty DM; Young SM; Samulski RJ
Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
[TBL] [Abstract][Full Text] [Related]
31. Second generation adeno-associated virus type 2-based gene therapy systems with the potential for preferential integration into AAVS1.
Owens RA
Curr Gene Ther; 2002 May; 2(2):145-59. PubMed ID: 12109212
[TBL] [Abstract][Full Text] [Related]
32. The cryptic life style of adeno-associated virus.
Berns KI; Linden RM
Bioessays; 1995 Mar; 17(3):237-45. PubMed ID: 7748178
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
